Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000117047 | SCV000151179 | benign | not specified | 2013-11-25 | criteria provided, single submitter | clinical testing | |
Claritas Genomics | RCV000117047 | SCV000222824 | benign | not specified | 2013-03-29 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000117047 | SCV000232615 | benign | not specified | 2014-11-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117047 | SCV000250368 | benign | not specified | 2014-08-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000756175 | SCV000287136 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000117047 | SCV000306616 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV004019630 | SCV000319340 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-02-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000659652 | SCV000781495 | likely benign | Connective tissue disorder | 2016-11-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001723679 | SCV000883901 | benign | not provided | 2023-09-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498511 | SCV002802026 | likely benign | Cardiac valvular dysplasia, X-linked; FG syndrome 2; Heterotopia, periventricular, X-linked dominant; Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked; Melnick-Needles syndrome; Oto-palato-digital syndrome, type I; Oto-palato-digital syndrome, type II; Terminal osseous dysplasia-pigmentary defects syndrome; Frontometaphyseal dysplasia 1 | 2021-09-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000117047 | SCV004039282 | benign | not specified | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000117047 | SCV001808390 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723679 | SCV001957322 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001723679 | SCV001965458 | likely benign | not provided | no assertion criteria provided | clinical testing |